Stratification of enhancers by relative signal strength in ChIP-seq assays has resulted in the establishment of super-enhancers as a widespread and useful tool for identifying cell type-specific, highly expressed genes and associated pathways. We have examined a distinct method of stratification that focuses on peak breadth, and use it to classify broad regions exhibiting histone modifications associated with gene activation as "hyperacetylated chromatin domains" (HCDs). We find that application of this analysis to multiple datasets serves to identify genes that are both more highly expressed and more closely aligned to cell identity than super-enhancer analysis does.
Fundamental issues regarding enhancer function, however, remain unclear. For example, the dominant model for how enhancers communicate with their cognate gene promoters, termed "looping," involves direct interactions between factors bound to enhancers and factors bound near promoters. Evidence for such interactions, however, has provided little insight into how a distal enhancer finds a gene promoter, or how it distinguishes among potential promoters in gene-dense regions. Moreover, some evidence suggests that mechanisms of enhancer-promoter communication may be more varied 3, 5 .
Additional insight into enhancer function can be obtained by discerning functional differences between them. One attempt to classify enhancers according to "strength,"
as determined by signal intensity in genome-wide ChIP-seq assays for associated enhancer marks, has led to the classification of super-enhancers, which by various analyses have been shown to be associated with highly-expressed genes that define cell identity 6, 7, 8 . Obvious functional differences have not emerged from studies of superenhancers, however, with the only reported distinction being a higher diversity and/or number of TF binding sites mapping to super-enhancers 9, 10 . Mechanistically, there is as yet no indication that, aside from "strength" of activation, these sequences are intrinsically any different from other enhancers that exhibit weaker signal for enhancerdefining marks.
We have previously investigated enhancer-associated histone modifications from the perspective of peak breadth, as opposed to signal strength. We characterized specific regions as "hyperacetylated chromatin domains" (HCDs), defined as continuous genomic regions exhibiting significant enrichment for histone hyperacetylation and other marks associated with active transcription, most notably H3K4 dimethylation (H3K4Me2). From this analysis, we identified a novel enhancer within the murine bglobin locus, termed HS-E1, which is required for the formation of such a broad region of histone hyperacetylation encompassing the two genes within the cluster that are expressed during primitive erythropoiesis 11, 12 . Our results suggested a distinction between enhancers that mediate broadly-distributed changes in chromatin structure vs.
enhancers that work via other mechanisms.
To further investigate this, we have performed ChIP-seq analyses of specific histone modifications in primary murine erythroid cells and ranked peaks according to breadth. We find that a ranking that utilizes a combination of two histone marks suffices to identify a subpopulation of genes that are both more highly expressed and more erythroid-specific than those associated with super-enhancers. Moreover, genetic manipulations of selected gene loci identify potential functional differences between enhancers located within such broad peaks and those that are not, and in addition reveal substantial complexity underlying conventional super-enhancers.
Results
Our prior studies suggested the existence of hyperacetylated chromatin domains (HCDs) controlled by enhancers at specific genomic regions, such as the murine bglobin locus 12 . In an effort to define the genome-wide occurrence and distribution of such domains, we performed and/or compiled a number of ChIP-seq and other datasets. These included (1) ChIP-seqs we performed using e14.5 murine fetal liver, which is comprised of 70-80% erythroid cells, using antibodies specific for H3K27 acetylation (H3K27Ac), and for H3K4 mono-, di-and trimethylation (H3K4Me1, H3K4Me2, H3K4Me3); (2) ATAC-seq 13 we performed using sorted proerythroblasts from e14.5 murine fetal liver; and (3) publicly available ChIP-seq datasets from e14.5 murine fetal liver for the erythroid transcription factors GATA-1 and SCL/Tal1 14 (Figure   1 ).
Our previous definition of hyperacetylated domains involved broad regions of continuous enrichment for specific histone modifications -most often, histone hyperacetylation and H3K4Me2. We therefore analyzed our H3K27Ac and H3K4Me2
ChIP-seq datasets derived from e14.5 murine fetal liver by ranking MACS2 15 peaks by breadth. The establishment of a formal definition for a domain requires the application of a subjective cutoff value; for our purposes, rather than an absolute peak breadth we chose the top 2% of MACS2 peaks ranked by breadth. We did this because we found that a cutoff based on ranking, as opposed to absolute peak breadth, translated more consistently between different datasets. Our other criterion was that this produced a list of HCDs that was comparable in size to the list of super-enhancers called from the same datasets (see below), and thus facilitated a comparison of the two methods.
To arrive at this list of HCDs, we first intersected the replicates of our ChIP-seqs for each histone modification (H3K27Ac or H3K4Me2), and then applied the 2% cutoff to each intersection, resulting in 420 H3K27Ac and 760 H3K4Me2 peaks. We then identified the H3K27Ac and H3K4Me2 peaks that overlapped within the genome and merged them by taking their union. This resulted in a final tally of 216 regions we term When choosing criteria to call super-enhancers, we wanted to stay as true to the original method as possible, while also making sure the datasets were comparable to our hyperacetylated domains. We therefore used lineage specific transcription factor (GATA-1 and SCL/Tal1) peaks to identify a set of enhancers in fetal liver 14 . We then ranked these enhancers based on signal intensity in our H3K27Ac and H3K4Me2 ChIPseqs, since these are the marks that we used to identify hyperacetylated domains. We used the ROSE algorithm 6, 7 with the default stitching distance (12.5 kb) and a +/-500bp TSS exclusion zone, which resulted in 307 super-enhancers ranked on H3K27Ac and 214 super-enhancers ranked on H3K4Me2. To identify super-enhancers for both H3K27Ac and H3K4Me2 we took the union of the 307 and 214 super enhancers, only where these regions overlapped, for a final tally of 173 murine erythroid superenhancers. ( Supplementary Fig. 1b , Supplementary File 1).
Insofar as signal strength has been taken as a proxy for enhancer strength, the fundamental utility of super-enhancer identification has been the ability to pick out associated genes that are presumably the most important factors in cell-type specificity.
We therefore compared the properties of genes associated with HCDs to those associated with super-enhancers. For association of genes with super-enhancers, the most common method in the literature is "nearest neighbor" (i.e. nearest active gene), and so we used this method to associate super-enhancers with genes. We used the same approximation for HCDs, although notably for 205 out of the 216 regions we have classified as HCDs in murine fetal liver, the nearest active genes are actually located within them. The remaining 11 HCDs all harbor peaks of H3K4Me3, suggesting the presence of unannotated gene promoters (not shown), but for the sake of consistency in this analysis we still associated these HCDs with the nearest annotated genes. Using a published database of Affymetrix-derived gene expression in murine fetal liver (ErythronDB 16, 17 ), we then compared expression levels for genes associated with HCDs and genes associated with super-enhancers ( Figure 2A ). We find that HCD-associated genes are expressed at significantly higher levels in murine fetal liver than those associated with super-enhancers.
Not only did we find that HCDs were associated with more highly expressed genes than super-enhancers, but we also found that they were associated with genes that are better able to identify erythroid cell types in the Mouse Gene Atlas than genes associated with super-enhancers, using Enrichr cell type analysis software 18, 19 ( Figure   2B , Supplementary File 2). Functional enrichment analysis, also performed through Enrichr, shows that genes associated with HCDs are more likely to identify terms that are specific for erythroid cells. Seven of the top ten most enriched terms for genes associated solely with HCDs are specific for erythroid biology, while in contrast, only two out of the top ten are erythroid-specific using genes associated solely with superenhancers ( Figure 2C , Supplementary File 3). Notably, genes found to be associated with both an HCD and a super-enhancer exhibit a distribution of expression levels similar to those associated with an HCD alone, and thus also higher than those associated only with super-enhancers. In Enrichr analysis, this population of genes also results in the identification of terms more obviously applicable to erythroid biology than with genes associated solely with super-enhancers. 0 40 80 120 160 a c b 26 14 Enrichr Combined Score ( is, we applied the same analyses to a selection of publicly available datasets. We were able to perform domain analysis and super-enhancer analysis on ChIP-seqs derived from human primary cultured CD34+ erythroid cells 20 in the exact same fashion as for our murine fetal liver-derived datasets (Figure 3 We performed additional comparisons of HCD and super-enhancer analyses using available datasets derived from non-erythroid murine tissues, specifically intestinal epithelium 21 ( Supplementary Figure 2 , Supplementary File 7) and retina 22, 23 ( Supplementary Figure 3 , Supplementary File 10). In these cases, while all rankings are still performed using H3K27Ac and H3K4Me2, enhancer calls for super-enhancer analysis are derived from ATAC-seq instead of TFs, and intestinal epithelial domains were reduced from the top 2% to the top 1% of H3K27Ac/H3K4Me2 peaks ranked by breadth, again to arrive at a list of HCDs comparable in size to the list of superenhancers (see Materials and Methods). In both cases, the HCDs identify more highly expressed genes ( Supplementary Figures 2A, 3A) , and genes more closely associated with the specific tissue type, than do super-enhancers (Supplementary Figures 2B-C, 3B-C, Supplementary Files 8-9,11-12). Enrichr Combined Score (log(p)⦁z) Our previous characterization of HS-E1 within the b-globin locus as an enhancer required for the formation of an HCD implied that classification of enhancers according to peak breadth could serve to distinguish between enhancers with different functions 12 .
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Figure 3: Comparison of genes associated with super-enhancers vs. HCDs in human erythroid cells. (a) Violin plots of expression of genes associated with
To investigate this, we performed CRISPR/Cas9-mediated genetic manipulation of selected gene loci in murine erythroleukemia (MEL) cells 24, 25 . These cells are transformed, but exhibit a phenotype similar to proerythroblasts, and they can be induced to mature (but not to enucleate) by incubation in 2% DMSO. Maturation is associated with cessation of cell division in a majority (>90%) of cells and dramatic upregulation of erythroid-specific genes, most notably the a-and b-globin genes.
As an example locus exhibiting an HCD, we chose the region harboring the gene encoding glycophorin A (Gypa), a late-stage erythroid cell surface marker that is highly upregulated upon MEL cell maturation. The region exhibits a substantial domain that encompasses the gene promoter and a pair of putative enhancers located within the third and fourth introns of the gene ( Figure 1B ). These enhancers, together with the region near (but not directly over) the gene promoter, are also called as a superenhancer by our ROSE-based analysis. Using a CRISPR/Cas9-based strategy we created a deletion of a 700 bp region encompassing the major GATA1 binding site within intron 3, while leaving exon 4 and the splice acceptor intact.
We measured expression of Gypa in differentiating (DMSO-treated) MEL cells, which more closely resemble e14.5 fetal liver than undifferentiated MEL cells, and saw that Gypa expression decreased >10-fold in cell lines harboring the enhancer deletion ( Figure 4A ). ChIP-qPCR analysis of the Gypa locus in these cells indicates that deletion of the enhancer has a significant effect on levels of H3K4Me2 ( Figure 4B ) and H3K27Ac ( Figure 4C ) observed across the entire region, consistent with a requirement for the enhancer in HCD formation.
Given that the Gypa HCD occurs largely within the transcribed region of the gene, however, it remains possible that the effect of enhancer deletion on histone modifications is a secondary consequence of decreased transcription. To address this, we created MEL cells harboring a deletion of the Gypa gene promoter. These cells exhibit little to no expression of Gypa ( Figure 4A ), but levels of histone modifications across the gene are not affected to nearly the same degree as with the enhancer deletion ( Figure 4B -C). The results suggest that the histone modifications we have identified as the Gypa HCD are, for the most part, a direct consequence of enhancer activity.
As an example locus exhibiting a super-enhancer, but not an HCD, we investigated the region harboring the gene encoding Tspan32, a member of the tetraspanin superfamily. The super-enhancer identified at this locus includes three putative individual elements, marked by GATA1 binding, located at -17 kb, -10 kb and +0.7 kb relative to the transcription start site (TSS). We created deletions of each of these enhancers individually by CRISPR/Cas9-mediated genome editing in MEL cells.
Notably, measurement of Tspan32 gene expression in differentiating MEL cells indicated that only deletion of the +0.7 enhancer had a significant effect ( Figure 5A ), To further investigate this behavior, we considered the possibility that the "nearest neighbor" assumption -e.g., that the super-enhancer or individual elements within it necessarily regulates only the Tspan32 gene -might not be valid, and so we expanded our analysis to include additional genes neighboring Tspan32. Hi-C data from murine cells 26 indicate that Tspan32 resides within a topologically associating domain (TAD) that contains two other genes that are expressed in erythroid cells, Cd81
(encoding another tetraspanin superfamily member) and Tssc4 (encoding a protein of unknown function), located 48 and 64 kb from the Tspan32 gene promoter, respectively.
Surprisingly, deletion of the +0.7 enhancer had significant effects on the expression of both genes ( Figure 5A ), which generally paralleled the effects we observed on the Tspan32 gene. Thus, the +0.7 enhancer is required for normal expression of multiple neighboring genes in differentiating MEL cells.
We then utilized a publicly available transcriptomic database (ErythonDB 16, 17 ) to examine the expression of Tspan32, Cd81 and Tssc4 during normal erythropoiesis.
This indicated that Tspan32 is substantially upregulated later in erythroid maturation, while Cd81 and Tssc4 are downregulated. We therefore examined gene expression in our various MEL cell lines prior to differentiation, as an approximation of an earlier stage of erythroid maturation than that modeled by DMSO-treated MEL cells. Interestingly, in this environment, normal expression levels of all three genes required the -10 kb element, while the other enhancers had smaller but still significant effects ( Figure 6 ).
This suggests that the components of the Tspan32 super-enhancer have differential Figure 6 ) suggesting a function of these enhancers that does not involve modification of chromatin.
Discussion
Ranking of enhancers by "strength" as determined by ChIP-seq signal intensity is now a highly common technique for meta-analysis of epigenomic data, with applications in revealing cell type-specific pathways and transcriptional regulatory networks. In this regard, the super-enhancer model has generated a great deal of interest, especially insofar as it can be applied to dysfunctional or disease states. In this study, however, we have demonstrated that for the specific purposes of identifying the genes and pathways most important for cell phenotype, a ranking according to peak breadth of regions identified by ChIP-seq using antibodies for two commonly assayed histone modifications is more useful. The combination of H3K4Me2 and H3K27Ac "domains"both of which are detected using widely available and highly robust antibodies -serves to identify genes that are both more highly expressed and more closely aligned to cell type than genes identified by super-enhancer analysis. Moreover, the protocol for classifying regions by peak breadth and identifying HCDs, which we include here (Supplemental Figure 1, Supplementary Files 13-14) is both more transparent and simpler to use than the ROSE algorithm. Notably, peak breadth in histone modification ChIP-seqs has previously been used to identify highly-expressed and/or cell type-specific genes. "Stretch enhancers," for example, have been defined as regions exhibiting continuous epigenomic signatures ("chromatin state" from ChromHMM 27 ) indicative of enhancers over spans of 3 kb or more 28 . This contrasts with our own analysis in two key respects. First, hyperacetylated domains encompass both enhancers and promoters and are not necessarily limited to either type of sequence element. Second, the "stretch enhancer" definition applies to fully 10% of all putative enhancer regions, while our own definition of a hyperacetylated domain is more restrictive.
There are several potential explanations for the differences in genes and pathways identified by HCD (peak breadth) vs. super-enhancer analysis. Assignment of genes to super-enhancers relies on the assumption that a given enhancer regulates the nearest active gene. This is, at best, an approximation, the accuracy of which is impossible to evaluate in the absence of comprehensive genetic analysis or other data, and difficult even then. In contrast, genes assigned to HCDs are nearly always (95%) located within them, and there is a logically greater certainty that a gene within an HCD is directly affected. Complexity arises in those cases involving multiple active genes within an HCD, and so even the domain concept involves a degree of approximation, but based on gene expression and cell type-specificity (Figures 2-3) , the uncertainty involved appears to be less than that inherent to super-enhancers.
To a certain extent, however, HCDs may be advantaged compared to superenhancers due to purely technical aspects of ChIP-seq analysis. Ranking by peak intensity (e.g. peak height) is limited because mapping algorithms routinely discard duplicate reads as a precaution against PCR artifacts arising from library construction.
Reads therefore cannot stack on top of each other, and the maximum height a given peak can achieve is artificially limited. Ranking by peak breadth avoids this necessary limitation and therefore may present a more sensitive metric for determining the strongest and/or most cell type-specific enhancers.
An important consideration is the potential mechanisms that underlie differences in peak intensity vs. differences in peak breadth. In ChIP-seqs, which assay large numbers of cells at once, differences in peak intensity most likely reflect differences in binding affinity between enhancer regions; thus, a higher peak intensity for a transcription factor reflects a higher proportion of alleles crosslinked to that factor (whether directly or indirectly), and for histone modifications a higher proportion of alleles associated with the cognate enzyme(s). In either case, binding does not necessarily invoke transcriptional activation of a neighboring gene.
In contrast, the largest peak breadths most likely arise from a mechanism distinct from higher binding affinity. In our previous investigation of the HCD within the murine b-globin locus, we demonstrated that the association of specific histone modifications was not intrinsic to the entire sequence underlying the HCD, but was a function of a smaller enhancer region within it. We demonstrate a similar effect for an enhancer within the Gypa gene in this study. This requirement strongly suggests that the histone modification pattern associated with an HCD spreads in some fashion from the regulatory element. Regardless of the mechanism that underlies such spreadingwhether a specific mechanism akin to the formation of heterochromatic domains, or simple "spill-over" from an excess of chromatin modifiers -a broad domain implies a high degree of binding and activity, and insofar as the vast majority of HCDs subsume gene promoters, of activity at transcription initiation sites. Rather than implying that a greater proportion of alleles in the cell population harbor modified nucleosomes, an HCD implies a greater absolute quantity of modified histones at each allele, which could conceivably contribute to stability of the active transcriptional state in the nuclear environment.
Notably, ranking of H3K27Ac/H3K4Me2 peaks by breadth is potentially useful in An additional concern is the "stitching" step of super-enhancer analysis, in which putative enhancer regions located within a specific distance of each other (the default in the ROSE algorithm is 12.5 kb, and so this is most often used) are considered as a single element, under the assumption that closely-spaced enhancers work together in activation of the same gene or genes 6, 7, 8 . Some studies have questioned the general validity of this assumption 10, 29 , and our own analysis of the Tspan32 locus presents a clear example of how the super-enhancer concept tends to oversimplify more complex patterns of gene regulation. We found that the Tspan32 super-enhancer, comprised of three distinct candidate enhancer regions, is in fact involved in the regulation of two additional genes as well as Tspan32. Moreover, individual enhancers within the superenhancer exhibit very different roles, with the -10 kb enhancer required solely in undifferentiated MEL cells, the +0.7 kb enhancer required solely in differentiating MEL cells, and the -17 kb enhancer showing no requirement at all. Based on such behavior, the classification of these three elements as a single super-enhancer appears to obscure the functions of these regions more than it illuminates them.
While super-enhancers can identify highly expressed genes that characterize cell identity, we find that HCDs define a set of genes that exhibit higher expression, and better specify cell lineage. Furthermore, as an analytical tool, HCDs present additional advantages over super-enhancers, including a significantly simpler workflow. Our results suggest that super-enhancers do not have a function distinct from that of typical enhancers, and that clustering of enhancer elements does not necessarily imply cooperative function, whereas there appears to be a functional difference between at least some of the enhancers located within HCDs, involving modulation of long-range chromatin structure, compared to other enhancers.
Materials & Methods
Mice and tissues
Mice (C57BL/6J) were mated overnight and the vaginal plug verified the next morning, indicating embryonic day 0.5 (e0.5). At e14.5 pregnant mice were killed by cervical dislocation for collection of fetal liver. Animal experiments were approved by the University of Rochester Committee on Animal Resources. For ATAC-seq (see below), E14.5 liver-derived proerythroblasts were sorted as previously described 30 , but also including Cd117 staining using a FACS Aria-II. Briefly, larger single cells that were Ter lo CD117+CD44 hi were collected. These cells are also positive for CD71.
ChIP-seq
Chromatin immunoprecipitation was performed as previously described 31 . Briefly, 2 x 10 7 cells were washed with PBS once, then cross-linked with 1% formaldehyde for 10 minutes at room temperature. Cross-linking was quenched with 5 M glycine for 1 minute at room temperature, and cells were washed with PBS once. Cells were incubated in swelling buffer for 20 minutes on ice, followed by dounce homogenization to isolate cross-linked nuclei. Nuclei were placed in lysis buffer for 30 minutes and then sonicated into ~200 bp fragments using a Diagenode Bioruptor. Samples were diluted and immunoprecipitated with an antibody to H3K4Me1 (Abcam #ab8895), H3K4Me3 (Active Motif #39916), H3K27Ac (Active Motif #39134), H3K4Me2 (Millipore #07-030), or nonspecific rabbit immunoglobulin G (Millipore #12-370) on a rotator for 18 hrs. at 4°C.
DNA-protein complexes were recovered with protein G magnetic beads (Invitrogen).
Library preparation was performed as previously described 32 . Library quality was evaluated on a Bioanalyzer and sequencing was performed on a HiSeq 2500 Rapid
Run to obtain 1 × 50 bp reads.
ChIP-Seq Analysis
Illumina reads were converted to the fastq format using bcltofastq-1.8.4 with default parameters. Quality control and adapter removal was performed using Trimmomatic-0.32 33 Peaks were called for each replicate of each mark using MACS2 along with additional settings including (--broad -broad-cutoff 0.1 -B) using the total input control as the mock data file 15 . The intersection of each replicate was identified using bedtools intersect and was used for subsequent analyses 36 .
ATAC-Seq
ATAC-seq was performed as previously described 37 . Briefly, 5 x 10 4 sorted proerythroblasts were lysed by gently pipetting in cold lysis buffer. Cell lysate was resuspended in transposition reaction mix (Illumina) and incubated at 37°C for 30 min.
Reactions were purified using AmpureXP beads (Beckman Coulter) following manufacturer's protocol with minor changes. Beads were used at a 1:1.1 ratio and reactions were washed twice. After purification samples were amplified using 1 × NEBnext PCR master mix and 1.25 μM of custom Nextera PCR primers 1 and 2 38 . Libraries were amplified again for an additional 17-19 cycles and left side size selected with SPRIselect beads (Beckman Coulter) at a 1:1 ratio following manufacturer's protocol, then right side size selected with SPRIselect beads (Beckman Coulter) at a 1:0.5 ratio following manufacturer's protocol. Library quality was evaluated on a Bioanalyzer and sequencing was performed on a Hiseq2500v2 platform in rapid mode to generate 50 million reads per sample.
ATAC-seq Analysis
Illumina reads were converted to the fastq format using bcltofastq-1.8.4 with default parameters. Quality control and adapter removal was performed using Trimmomatic-0.32 33 using the following parameters "SLIDINGWINDOW:4:20 TRAILING:13 LEADING:13 ILLUMINACLIP:adapters.fasta:2:30:10 MINLEN:15". All quality reads were aligned to the mm9 reference genome using Bowtie-1.0.142 34 , suppressing multi-mapping reads using the '-m 1' parameters. All alignments were written in the SAM format (-S), converted to BAM and sorted for all subsequent analyses using samtools 35 .
Reads aligning to organism-specific blacklist regions and the mitochondrial genome are discarded. Accessible regions are identified using MACS2 15 and ATAC specific parameters (--nomodel --shift -100 --extsize 200).
RNA-Seq Analysis
Raw fastq files for publicly available datasets (GSE87064-SRR4253101 SRR4253102, GSE98724-SRR5520174 SRR55201745) were downloaded using fastqDump available in SRAtoolkit 21, 22, 23 . All reads were processed using trimmomatic 33 
Domain Analysis
The top 2% broadest peaks were filtered from the H3K4Me2 and H3K27Ac intersected replicates. Bedtools intersect was used to identify the intersection of these two tracks, which is what we define as a hyperacetylated domain 34 . Microarray expression data for e14.5 fetal liver (maturational stages proerythroblast, basophilic erythroblast, and polychromatic erythroblast) available through ErythronDB (http://www.cbil.upenn.edu/ErythronDB/resources.jsp) were downloaded and used to associate nearby gene expression to domains and non-domains 16, 17 . Domains were associated with nearby genes using bedtools closest, default settings. Enrichr (http://amp.pharm.mssm.edu/Enrichr/) was used to perform comprehensive enrichment analysis on associated genes 18, 19 .
Super-Enhancer Analysis
For the identification of super-enhancers within our H3K4Me2 and H3K27Ac datasets we used ROSE (http://younglab.wi.mit.edu/super_enhancer_code.html), created by the Young lab 6 . Input enhancers were defined as a merged peak set of all Gata1 and Tal1
replicates and a TSS_EXCLUSION_ZONE_SIZE of 500bp. Enrichr (http://amp.pharm.mssm.edu/Enrichr/) was used to perform comprehensive enrichment analysis on associated genes 18, 19 .
Analysis of Human ChIP-Seq and Microarray Data
Domains and super enhancers were identified and evaluated during human fetal erythropoiesis using publicly available data (GSE36985) 20 based on a nearest neighbor analysis using bedtools closest (default settings) 33 .
Enriched cell types were evaluated using Enrichr and the Human Gene Atlas. RNA expression log2(RMA) were downloaded from ArrayExpression (G_GEOD-36984) 18, 19, 20 .
CRISPR deletion
px458 plasmids harboring sgRNAs targeting specific regions of the mouse genome were engineered as previously described 41 (see Supplementary Table 1 ). MEL745a
cells were transfected with one plasmid targeting upstream and one plasmid targeting downstream sequence surrounding the enhancer using Lipofectamine 3000 (Invitrogen) according to manufacturer instructions. At 48 hrs. the cells were resuspended in D-PBS (Gibco) +0.5% FBS(Gemini), stained with DAPI(ThermoFisher), and the viable, GFP positive population was sorted in bulk. Seven days after sorting, cells were diluted to 1 cell/100µl in Dulbecco modified Eagle medium (Gibco) containing 20% FBS, 1%
Glutamax (Gibco), and 1% Pen/strep (Gibco) and plated in a 96 well plate. Homozygous deletions were identified through PCR of the region surrounding the targeted enhancer sequence, and PCR products were Sanger sequenced for confirmation.
Cell Culture
Cell lines were maintained at 37°C in a CO2-humidified atmosphere. MEL745a cells were cultured in Dulbecco modified Eagle medium containing 10% FBS, 1% Glutamax, and 1% Pen/strep. For induction, 2% dimethyl sulfoxide (Fisher) was added to the culture medium.
ChIP-qPCR
Cells were formaldehyde crosslinked, sonicated and immunoprecipitated, and DNA isolated as for the ChIP-sequencing, with minor differences. Nuclei were isolated from 1 x 10 7 cells for each experiment and then sonicated to ~500 bp fragments of genomic DNA using a Diagenode Bioruptor. Samples were diluted and immunoprecipitated with antibodies specific for H3K27Ac (Active Motif # 39134), H3K4Me2 (Millipore # 07-030), and nonspecific rabbit immunogloblulin G (Milipore # 12-370). Analysis was performed using qPCR and detected using the CFX Connect Real-Time PCR System and CFX Manager (Bio-Rad). Primers were designed to amplify regions within the Glycophorin A locus or Tspan32 locus, and as a negative control the Amylase gene promoter (a region that is inactive in erythroid cells)(see Supplementary Table 2 ).
qRT-PCR
RNA was isolated using TRIzol (Invitrogen) according to manufacturer instructions. One microgram of RNA was used to synthesize cDNA using the iScript cDNA synthesis kit (Bio-Rad). cDNA was amplified using iTaq Universal SYBR Green Supermix (Bio-Rad) and detected using the CFX Connect Real-Time PCR Sytem and CFX Manager (Bio-Rad). Primers were designed to amplify Gypa, Tspan32, Cd81, and Tssc4 cDNAs, and also ribosomal 18S as a control (see Supplementary Table 3 ).
Data Availability
All ChIP-seq and ATAC-seq data are available through GEO: GSE132130. Listings of the top ten GO terms for biological processes for the indicated groups;
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erythroid-specific terms are in boldface type. Listings of the top ten GO terms for biological processes for the indicated groups;
erythroid-specific terms are in boldface type. 
